Childhood-onset severe hypereosinophilic asthma: efficacy of benralizumab

Severe hypereosinophilic asthma in children is extremely rare. This letter adds to the existing literature by providing long-term follow-up, and is the first report of the marked efficacy of benralizumab after failure of other biologic treatments. https://bit.ly/2G7Tc2k

Detalles Bibliográficos
Autores principales: Just, Jocelyne, Bourgoin, Melisande, Amat, Flore, Cottel, Nathalie, Lambert, Nathalie, Wanin, Stephanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Original Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792776/
https://www.ncbi.nlm.nih.gov/pubmed/33447610
http://dx.doi.org/10.1183/23120541.00339-2020
_version_ 1783633861463244800
author Just, Jocelyne
Bourgoin, Melisande
Amat, Flore
Cottel, Nathalie
Lambert, Nathalie
Wanin, Stephanie
author_facet Just, Jocelyne
Bourgoin, Melisande
Amat, Flore
Cottel, Nathalie
Lambert, Nathalie
Wanin, Stephanie
author_sort Just, Jocelyne
collection PubMed
description Severe hypereosinophilic asthma in children is extremely rare. This letter adds to the existing literature by providing long-term follow-up, and is the first report of the marked efficacy of benralizumab after failure of other biologic treatments. https://bit.ly/2G7Tc2k
format Online
Article
Text
id pubmed-7792776
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-77927762021-01-13 Childhood-onset severe hypereosinophilic asthma: efficacy of benralizumab Just, Jocelyne Bourgoin, Melisande Amat, Flore Cottel, Nathalie Lambert, Nathalie Wanin, Stephanie ERJ Open Res Original Research Letters Severe hypereosinophilic asthma in children is extremely rare. This letter adds to the existing literature by providing long-term follow-up, and is the first report of the marked efficacy of benralizumab after failure of other biologic treatments. https://bit.ly/2G7Tc2k European Respiratory Society 2020-12-21 /pmc/articles/PMC7792776/ /pubmed/33447610 http://dx.doi.org/10.1183/23120541.00339-2020 Text en Copyright ©ERS 2020 http://creativecommons.org/licenses/by-nc/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Original Research Letters
Just, Jocelyne
Bourgoin, Melisande
Amat, Flore
Cottel, Nathalie
Lambert, Nathalie
Wanin, Stephanie
Childhood-onset severe hypereosinophilic asthma: efficacy of benralizumab
title Childhood-onset severe hypereosinophilic asthma: efficacy of benralizumab
title_full Childhood-onset severe hypereosinophilic asthma: efficacy of benralizumab
title_fullStr Childhood-onset severe hypereosinophilic asthma: efficacy of benralizumab
title_full_unstemmed Childhood-onset severe hypereosinophilic asthma: efficacy of benralizumab
title_short Childhood-onset severe hypereosinophilic asthma: efficacy of benralizumab
title_sort childhood-onset severe hypereosinophilic asthma: efficacy of benralizumab
topic Original Research Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792776/
https://www.ncbi.nlm.nih.gov/pubmed/33447610
http://dx.doi.org/10.1183/23120541.00339-2020
work_keys_str_mv AT justjocelyne childhoodonsetseverehypereosinophilicasthmaefficacyofbenralizumab
AT bourgoinmelisande childhoodonsetseverehypereosinophilicasthmaefficacyofbenralizumab
AT amatflore childhoodonsetseverehypereosinophilicasthmaefficacyofbenralizumab
AT cottelnathalie childhoodonsetseverehypereosinophilicasthmaefficacyofbenralizumab
AT lambertnathalie childhoodonsetseverehypereosinophilicasthmaefficacyofbenralizumab
AT waninstephanie childhoodonsetseverehypereosinophilicasthmaefficacyofbenralizumab

Ejemplares similares